Effects of Gonadotropin-releasing Hormone Agonist Treatment on Final Adult Height in Boys with Idiopathic Central Precocious Puberty

Overview

Journal Ann Pediatr Endocrinol Metab

Specialty Pediatrics

Date 2021 May 21

PMID 34015899

Citations 5

Authors

Ah Young Cho

Su Yeong Ko

Jae Hee Lee

Eun Young Kim

Affiliations

Soon will be listed here.

Abstract

Purpose: There are few reports on the therapeutic effects of gonadotropin-releasing hormone agonists in boys with central precocious puberty, and studies reported in Korea are very rare. We aimed to assess the significance of clinical factors and the effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys diagnosed with central precocious puberty.

Methods: We retrospectively evaluated the medical records of 18 boys treated for idiopathic central precocious puberty between 2007 and 2018 at Chosun University Hospital. Gestational age, birth weight, and parental height were assessed at the initial visit. Chronological age, bone age, bone age/chronological age ratio, height and height standard deviation scores, predicted adult height, body mass index, and hormone levels were assessed during the treatment period.

Results: At the time of diagnosis, the chronological age was 9.9±0.6 years, the bone age was 11.6±1.0 years, and the bone age/chronological age ratio was 1.20±0.1. The bone age/chronological age ratio decreased significantly to 1.12±0.1 at the end of treatment (P<0.05). The luteinizing hormone/follicular stimulating hormone ratios were 3.4±1.2, 0.6±0.4, and 0.6±1.0 at the start of treatment, after 1 year of treatment, and at the end of treatment, respectively. After gonadotropin-releasing hormone agonist treatment, the final adult height reached 172.0±4.8 cm compared to the target height range of 171.0±4.0 cm.

Conclusion: In boys with central precocious puberty, gonadotropin-releasing hormone agonist treatment improved growth potential.

Citing Articles

Growth plate closure and therapeutic interventions.

Cho J, Jung H, Shim K Clin Exp Pediatr. 2024; 67(11):553-559.

PMID: 39463341 PMC: 11551597. DOI: 10.3345/cep.2023.00346.

Central precocious puberty: is routine brain MRI screening necessary for girls?: Commentary on "Brain magnetic resonance imaging (MRI) findings in central precocious puberty patients: is routine MRI necessary for newly diagnosed patients?".

Lee H Ann Pediatr Endocrinol Metab. 2023; 28(3):155-156.

PMID: 37798890 PMC: 10556437. DOI: 10.6065/apem.2322096edi07.

Commentary on "Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty&quot.

Kwon A Ann Pediatr Endocrinol Metab. 2023; 28(1):3-4.

PMID: 37015774 PMC: 10073027. DOI: 10.6065/apem.2321125edi05.

Final adult height in children with central precocious puberty - a retrospective study.

Knific T, Lazarevic M, Zibert J, Obolnar N, Aleksovska N, Suput Omladic J Front Endocrinol (Lausanne). 2022; 13:1008474.

PMID: 36531464 PMC: 9757689. DOI: 10.3389/fendo.2022.1008474.

Commentary on "Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty".

Cheon C Ann Pediatr Endocrinol Metab. 2022; 26(4):215-216.

PMID: 34991297 PMC: 8749018. DOI: 10.6065/apem.2120134edi01.

References

Guaraldi F, Beccuti G, Gori D, Ghizzoni L . MANAGEMENT OF ENDOCRINE DISEASE: Long-term outcomes of the treatment of central precocious puberty. Eur J Endocrinol. 2015; 174(3):R79-87. DOI: 10.1530/EJE-15-0590. View

Carel J, Leger J . Clinical practice. Precocious puberty. N Engl J Med. 2008; 358(22):2366-77. DOI: 10.1056/NEJMcp0800459. View

Mul D, Oostdijk W, Otten B, Rouwe C, Jansen M, Delemarre-van de Waal H . Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience. J Pediatr Endocrinol Metab. 2000; 13 Suppl 1:765-72. DOI: 10.1515/jpem.2000.13.s1.765. View

Tarim O . Height predictions by Bayley-Pinneau method may misguide pediatric endocrinologists. Turk J Pediatr. 2014; 55(5):485-92. View

Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwe C . Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child. 1996; 75(4):292-7. PMC: 1511728. DOI: 10.1136/adc.75.4.292. View

Oerter K, Manasco P, Barnes K, Jones J, Hill S, Cutler Jr G . Adult height in precocious puberty after long-term treatment with deslorelin. J Clin Endocrinol Metab. 1991; 73(6):1235-40. DOI: 10.1210/jcem-73-6-1235. View

Tanaka T, Niimi H, Matsuo N, Fujieda K, Tachibana K, Ohyama K . Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty. J Clin Endocrinol Metab. 2004; 90(3):1371-6. DOI: 10.1210/jc.2004-1863. View

De Sanctis V, Corrias A, Rizzo V, Bertelloni S, Urso L, Galluzzi F . Etiology of central precocious puberty in males: the results of the Italian Study Group for Physiopathology of Puberty. J Pediatr Endocrinol Metab. 2000; 13 Suppl 1:687-93. DOI: 10.1515/jpem.2000.13.s1.687. View

Lahlou N, Carel J, Chaussain J, Roger M . Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics. J Pediatr Endocrinol Metab. 2000; 13 Suppl 1:723-37. DOI: 10.1515/jpem.2000.13.s1.723. View

10.

Bertelloni S, Baroncelli G, Sorrentino M, Perri G, Saggese G . Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr. 1998; 157(5):363-7. DOI: 10.1007/s004310050831. View

11.

Mul D, Fredriks A, Buuren S, Oostdijk W, Verloove-Vanhorick S, Wit J . Pubertal development in The Netherlands 1965-1997. Pediatr Res. 2001; 50(4):479-86. DOI: 10.1203/00006450-200110000-00010. View

12.

Klein K, Barnes K, Jones J, Feuillan P, Cutler Jr G . Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab. 2001; 86(10):4711-6. DOI: 10.1210/jcem.86.10.7915. View

13.

Lee H, Yoon J, Park K, Hwang J . Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty. PLoS One. 2018; 13(8):e0201906. PMC: 6104939. DOI: 10.1371/journal.pone.0201906. View

14.

Bayley N, PINNEAU S . Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952; 40(4):423-41. DOI: 10.1016/s0022-3476(52)80205-7. View

15.

Lee J, Kim J, Yang A, Cho S, Jin D . Etiological trends in male central precocious puberty. Ann Pediatr Endocrinol Metab. 2018; 23(2):75-80. PMC: 6057022. DOI: 10.6065/apem.2018.23.2.75. View

16.

Teilmann G, Pedersen C, Jensen T, Skakkebaek N, Juul A . Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries. Pediatrics. 2005; 116(6):1323-8. DOI: 10.1542/peds.2005-0012. View

17.

Heger S, Partsch C, Sippell W . Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab. 1999; 84(12):4583-90. DOI: 10.1210/jcem.84.12.6203. View

18.

Rizzo V, De Sanctis V, Corrias A, Fortini M, Galluzzi F, Bertelloni S . Factors influencing final/near-final height in 12 boys with central precocious puberty treated with gonadotrophin-releasing hormone agonists. Italian Study Group of Physiopathology of Puberty. J Pediatr Endocrinol Metab. 2000; 13 Suppl 1:781-6. DOI: 10.1515/jpem.2000.13.s1.781. View

19.

Cho A, Ko S, Lee J, Kim E . Relationship between final adult height and birth weight after gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty. Ann Pediatr Endocrinol Metab. 2020; 25(1):24-30. PMC: 7136506. DOI: 10.6065/apem.2020.25.1.24. View

20.

Alikasifoglu A, Vuralli D, Gonc E, Ozon A, Kandemir N . Changing Etiological Trends in Male Precocious Puberty: Evaluation of 100 Cases with Central Precocious Puberty over the Last Decade. Horm Res Paediatr. 2015; 83(5):340-4. DOI: 10.1159/000377678. View